Organization · Type 2 NPI
Oncology Pharmacy Services, Inc.
Specialty Pharmacy · Bedford, TX
NPI number
1033155049
Active
Practice location
1609 Hospital Pkwy
Bedford, TX 76022-6920
Fax (817) 359-9025
Mailing address
PO Box 731145
Dallas, TX 75373-1145
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Pharmacy | 333600000X | 20166 (TX) |
| Community/Retail Pharmacy | 3336C0003X | None listed |
| Specialty Pharmacy Primary | 3336S0011X | None listed |
Specialty Pharmacy: A pharmacy that dispenses generally low volume and high cost medicinal preparations to patients who are undergoing intensive therapies for illnesses that are generally chronic, complex and potentially life threatening. Often these therapies require specialized delivery and administration.
16 other providers at this address
- Ami Kanti Patel-Yadav, MDRadiation Oncology Physician Bedford, TX NPI 1164867461
- Ana Maria Rojas, MDHematology & Oncology Physician Bedford, TX NPI 1235305608
- Catherine Michelle Jennings, MDSurgical Oncology Physician Bedford, TX NPI 1841789740
- Delia Rose Gutierrez, RNRegistered Nurse Bedford, TX NPI 1124959580
- Laura Nasrallah, FNPFamily Nurse Practitioner Bedford, TX NPI 1558978569
- Leah Zhrebker, MDHematology & Oncology Physician Bedford, TX NPI 1811254485
- Nicholas LevonyakHematology & Oncology Physician Bedford, TX NPI 1588105852
- Ramsey Keyes, FNPFamily Nurse Practitioner Bedford, TX NPI 1174194427
- Randall Thomas Davis, MDHematology & Oncology Physician Bedford, TX NPI 1427091339
- Raulee Morello, MDSurgical Oncology Physician Bedford, TX NPI 1073961751
- Ravi Patel, MDHematology & Oncology Physician Bedford, TX NPI 1366736969
- Robert Dave Enriquez Buot, MSN, APRN, FNP-CFamily Nurse Practitioner Bedford, TX NPI 1447711759
About NPI 1033155049
Oncology Pharmacy Services, Inc.'s National Provider Identifier is 1033155049, issued on Jun 20, 2006. The primary taxonomy on file is Specialty Pharmacy (3336S0011X), and the practice location is in Bedford, TX. The record was last updated on Oct 19, 2026.